• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (53)
    • Proof-of-Concept Study to Assess the Nociceptin Receptor Antagonist LY2940094 as a New Treatment for Alcohol Dependence.
    • Validation of machine learning models to detect amyloid pathologies across institutions.
    • Expression of beta-galactosidase in mouse brain: utilization of a novel nonreplicative Sindbis virus vector as a neuronal gene delivery system.
    • Mitochondrially targeted ceramide LCL-30 inhibits colorectal cancer in mice.
    • Bone morphogenetic protein 3B silencing in non-small-cell lung cancer.
    • See All 53 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Bone morphogenetic protein 3B silencing in non-small-cell lung cancer.

Bone morphogenetic protein 3B silencing in non-small-cell lung cancer. Oncogene. 2004 Apr 29; 23(20):3521-9.

View in: PubMed

subject areas
  • Bone Morphogenetic Protein 3
  • Bone Morphogenetic Proteins
  • Carcinoma, Non-Small-Cell Lung
  • DNA Methylation
  • Gene Expression Regulation, Neoplastic
  • Gene Silencing
  • Growth Differentiation Factor 10
  • Humans
  • Lung Neoplasms
  • Promoter Regions, Genetic
  • Tumor Cells, Cultured

authors with profiles
  • Gustavo Leone
  • Cynthia Timmers